Peptide Hormone Or Derivative Utilizing Patents (Class 514/5.3)
  • COMPOUND FOR CONTROLLING APPETITE
    Publication number: 20100272727
    Abstract: Insl5 has been found to be orexigenic, i.e. it increases appetite. Insl5, or a derivative or fragment thereof that retains the ability to bind to the GPR100 receptor, or an Insl5 antibody, are useful in therapy, in particular to treat anorexia nervosa, bulimia, cachexia or wasting disease.
    Type: Application
    Filed: September 5, 2008
    Publication date: October 28, 2010
    Applicant: TAKEDA PHARMACEUTICAL COMPANY LIMITED
    Inventors: Johannes Grosse, Helen Heffron, Kate Day
  • METHOD OF PREVENTING OR TREATING BODY WEIGHT DISORDERS BY EMPLOYING CLUSTERIN
    Publication number: 20100256057
    Abstract: Clusterin possesses an excellent anorexigenic effect and, accordingly, is useful for treating or preventing obesity or an obesity-related disorder. Co-administration of sub-clinical dose of clustrin potentiates the anorexigenic effect of leptin.
    Type: Application
    Filed: May 7, 2007
    Publication date: October 7, 2010
    Inventors: Min-Seon Kim, Namkoong Churl, Pil-Geurn Jang, Byung-Soo Yoon
  • Orally Bioavailable Lipid-Based Constructs
    Publication number: 20100247625
    Abstract: The present invention is embodied by a composition capable inducing weight loss in a patient in need thereof.
    Type: Application
    Filed: March 26, 2010
    Publication date: September 30, 2010
    Inventors: W. Blair Geho, John R. Lau